Literature DB >> 9125573

An in vitro-differentiated human cell line as a model system to study the interaction of Neisseria gonorrhoeae with phagocytic cells.

C R Hauck1, D Lorenzen, J Saas, T F Meyer.   

Abstract

The extreme host specificity of pathogenic neisseriae limits investigations aimed at the analysis of bacterial-host interactions almost completely to the use of in vitro models. Although permanent epithelial and endothelial cell lines are already indispensable tools with respect to initial infection processes, studies concerning the interaction of neisseriae with phagocytic cells have been confined to primary human blood cells. We investigated the use of human leukemia-derived monocytic and myelomonocytic cell lines that can be differentiated in vitro towards phagocytic cells by a panel of chemical and biological reagents including cytokines, vitamin analogs, and antileukemia drugs. Whereas tumor necrosis factor alpha, gamma interferon, bufalin, or granulocyte-macrophage colony-stimulating factor only marginally increased the ability of monocytic MonoMac-6 and myelomonocytic JOSK-M cells to interact with the bacteria, retinoic acid and vitamin D3 treatment for 2 to 4 days led to highly phagocytic cells that internalized gonococci in an Opa protein-specific manner. This is comparable to the phagocytosis by primary monocytes from human blood, where more than 80% of cells are infected with intracellular bacteria. The increased phagocytic activity of JOSK-M cells following in vitro differentiation was paralleled by enhanced oxidative burst capacity. Whereas undifferentiated cells responded to neither phorbol 12-myristate 13-acetate nor other known soluble and particulate stimuli, cells incubated with retinoic acid and bufalin showed the same pattern and the same intensity of oxidative burst activity in response to Neisseria gonorrhoeae as primary cells: Opa-expressing gonococci elicited an oxidative burst, whereas Opa- gonococci did not. The surface expression of major histocompatibility complex (MHC) class II molecules was only slightly changed after retinoic acid treatment. Also, phagocytosis of gonococci had no influence on MHC class II surface expression. Taken together, our results demonstrate that in vitro-differentiated human myelomonocytic JOSK-M cells provide a suitable model for the study of a variety of aspects of the gonococcal interaction with phagocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125573      PMCID: PMC175232          DOI: 10.1128/iai.65.5.1863-1869.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  Variation and control of protein expression in Neisseria.

Authors:  T F Meyer; C P Gibbs; R Haas
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

2.  Pilus genes of Neisseria gonorrheae: chromosomal organization and DNA sequence.

Authors:  T F Meyer; E Billyard; R Haas; S Storzbach; M So
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

Review 3.  Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection.

Authors:  N E Reiner
Journal:  Immunol Today       Date:  1994-08

4.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

5.  Gonococci-human polymorphonuclear leukocyte interactions: metabolic studies associated with attachment and ingestion.

Authors:  A G Krieger; N L Schiller; R B Roberts
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

6.  1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells.

Authors:  C Miyaura; E Abe; T Kuribayashi; H Tanaka; K Konno; Y Nishii; T Suda
Journal:  Biochem Biophys Res Commun       Date:  1981-10-15       Impact factor: 3.575

7.  Construction of Hermes shuttle vectors: a versatile system useful for genetic complementation of transformable and non-transformable Neisseria mutants.

Authors:  E M Kupsch; D Aubel; C P Gibbs; A F Kahrs; T Rudel; T F Meyer
Journal:  Mol Gen Genet       Date:  1996-03-20

8.  Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes.

Authors:  J Gercken; J Pryjma; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).

Authors:  S Tsuchiya; M Yamabe; Y Yamaguchi; Y Kobayashi; T Konno; K Tada
Journal:  Int J Cancer       Date:  1980-08       Impact factor: 7.396

10.  Interactions of Neisseria meningitidis with human monocytes.

Authors:  G McNeil; M Virji; E R Moxon
Journal:  Microb Pathog       Date:  1994-02       Impact factor: 3.738

View more
  5 in total

1.  Tyrosine phosphatase SHP-1 is involved in CD66-mediated phagocytosis of Opa52-expressing Neisseria gonorrhoeae.

Authors:  C R Hauck; E Gulbins; F Lang; T F Meyer
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

2.  Helicobacter pylori resists phagocytosis by macrophages: quantitative assessment by confocal microscopy and fluorescence-activated cell sorting.

Authors:  N Ramarao; T F Meyer
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  CD66-mediated phagocytosis of Opa52 Neisseria gonorrhoeae requires a Src-like tyrosine kinase- and Rac1-dependent signalling pathway.

Authors:  C R Hauck; T F Meyer; F Lang; E Gulbins
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

Review 4.  Pathogenic Neisseria--interplay between pro- and eukaryotic worlds.

Authors:  T F Meyer
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

5.  Granulocyte CEACAM3 is a phagocytic receptor of the innate immune system that mediates recognition and elimination of human-specific pathogens.

Authors:  Tim Schmitter; Franziska Agerer; Lisa Peterson; Petra Munzner; Christof R Hauck
Journal:  J Exp Med       Date:  2004-01-05       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.